{
    "Trade/Device Name(s)": [
        "FDTX Glucose Control Solution"
    ],
    "Submitter Information": "Fujirebio Diagnostics Texas Inc.",
    "510(k) Number": "K080273",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062347",
        "K060426"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "June 17, 2008",
    "Summary Letter Received Date": "June 17, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "Plastic bottle with dropper-tip"
    ],
    "Instrument(s)/Platform(s)": [
        "Bayer Ascensia BREEZE 2 Blood Glucose Monitor"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for FDTX Glucose Control Solution used as a control material for verifying performance of Bayer Ascensia BREEZE 2 Blood Glucose Monitor",
    "Indications for Use Summary": "For in vitro diagnostic use by healthcare professionals and home users with diabetes mellitus to assess the performance of the BREEZE 2 Blood Glucose Monitor",
    "fda_folder": "Clinical Chemistry"
}